Table 3:
Multivariate analysis of prognostic and treatment variables associated with recurrence-free survival
| Parameters | Hazard ratio (95% confidence interval) | P-valuea |
|---|---|---|
| Age | 1.000 (0.988, 1.012) | 1.00 |
| Histology | ||
| NETT (vs TC) | 1.156 (0.680, 1.967) | 0.59 |
| pStage | 0.005 | |
| III (vs I/II/IIa/IIb) | 1.912 (1.108, 3.301) | 0.020b |
| IVa (vs I/II/IIa/IIb) | 2.957 (1.562, 5.596) | <0.001b |
| IVb (vs I/II/IIa/IIb) | 2.706 (1.429, 5.124) | 0.002b |
| Resection status | ||
| R1/2 (vs R0) | 1.622 (1.136, 2.317) | 0.008 |
| Chemotherapy | ||
| Yes (vs no) | 1.293 (0.867, 1.927) | 0.21 |
| Radiotherapy | ||
| Yes (vs no) | 0.506 (0.351, 0.731) | <0.001 |
| Tumour size | 1.004 (0.953, 1.058) | 0.89 |
| Gender | ||
| Female (vs male) | 1.378 (0.968, 1.961) | 0.075 |
NETT: neuroendocrine thymic tumour; TC: thymic carcinoma.
aLikelihood ratio P-value from a Cox model.
bWald P-values.